Status:

TERMINATED

Determination of the Prevalence and Severity of Expiratory Flow Limitation in Chronic Obstructive Pulmonary Disease Patients

Lead Sponsor:

Philips Respironics

Conditions:

Chronic Obstructive Pulmonary Disease

Noninvasive Ventilation

Eligibility:

All Genders

40-80 years

Brief Summary

Expiratory Flow Limitation (EFL) occurs when the airways become compressed, which usually results when the pressure outside the airway exceeds the pressure inside the airway. EFL can be detected using...

Detailed Description

This will be a cross-sectional, non-randomized epidemiology study designed to assess the prevalence and severity of expiratory flow limitation in a community COPD population. In the study we will also...

Eligibility Criteria

Inclusion

  • Age \> 40 years of age; \< 80 years of age
  • Ability to provide consent
  • Diagnosis of Chronic Obstructive Pulmonary Disease (COPD)

Exclusion

  • Any major non COPD uncontrolled disease or condition, such as congestive heart failure, malignancy, liver or renal insufficiency (that requires current evaluation for liver or renal transplantation or dialysis), amyotrophic lateral sclerosis, or severe stroke, or other condition as deemed appropriate by investigator as determined by review of medical history and / or participant reported medical history
  • Suffering from a COPD exacerbation at the time of data collection or in the 30 days prior to data collection
  • Self-reported Pregnancy
  • Employee or family member that is affiliated with Philips Respironics
  • History of bullous emphysema
  • History of pneumothorax
  • Evidence of acute sinusitis or otitis media
  • Hypotension
  • Participants at risk for aspiration of gastric contents
  • Epistaxis
  • Participants in respiratory failure
  • Inability to maintain a patent airway or adequately clear secretions

Key Trial Info

Start Date :

March 14 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 15 2023

Estimated Enrollment :

57 Patients enrolled

Trial Details

Trial ID

NCT03851510

Start Date

March 14 2019

End Date

November 15 2023

Last Update

October 24 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Florida, Jacksonville

Jacksonville, Florida, United States, 32209